Integrative “Omic” Analysis for Tamoxifen Sensitivity through Cell Based Models

Open Access

Peer-reviewed

Research Article

Liming Weng,

Affiliation Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
Dana Ziliak,

Affiliation Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
Bonnie LaCroix,

Affiliation Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
Paul Geeleher,

Affiliation Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯
R. Stephanie Huang

* E-mail: rhuang@medicine.bsd.uchicago.edu

Affiliation Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
⨯

Reader Comments (0)

MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Single nucleotide polymorphisms
Is the Subject Area "Single nucleotide polymorphisms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Phenotypes
Is the Subject Area "Phenotypes" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Genome-wide association studies
Is the Subject Area "Genome-wide association studies" applicable to this article?

Thanks for your feedback.